Shenzhen Zhongge Biotechnology Co. Ltd. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to an interleukin-1 ...
Katalytic Therapeutics Inc. has divulged proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to a phosphodiesterase PDE4-targeting ...
The company granted stock options to purchase an aggregate of 157,150 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 107,500 shares of Nurix common ...
TRIMTECH Therapeutics’s incredible $31million seed funding haul will be deployed to develop treatments for severe ...
4d
AZoLifeSciences on MSNInvestigating Ubiquitination's Role in Cancer Stem Cell RegulationThis review highlights the critical role of ubiquitination in governing the functionality of cancer stem cells (CSCs), ...
After the presentations at the 2025 #21ToWatch ceremony at Botanic House there was a chance to meet the winners and - yes! - ...
This paper presents the important finding that BNIP3/NIX, a mitophagy receptor, and its binding to ATG18 are required for mitophagy during muscle cell reorganization in Drosophila. Although the ...
After hours: March 12 at 4:29:45 PM EDT Loading Chart for KPTI ...
Office 365 E5 is a cloud-based suite of Microsoft 365 productivity apps combined with advanced voice, analytics, security, and compliance services. Install Microsoft 365 on up to five PCs or Macs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results